← feed

Is NCT03146013 results overdue?

Yes — results are overdue. Primary completion was 2017-05-31; the FDAAA-801 reporting deadline (2018-05-31) passed 2943 days ago and no results are posted on ClinicalTrials.gov.

Dual Algorithm Post Market Clinical Study

NCT IDNCT03146013 ↗
SponsorMP Biomedicals, LLC (INDUSTRY)
Phase
StatusCOMPLETED
Primary completion2017-05-31 (ACTUAL)
Reporting deadline2018-05-31 (completion + 365d)
Days overdue2943
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: yes
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 57702f2efcc7e640… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03146013. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →